Skip to main content
Erschienen in: Inflammopharmacology 2/2018

25.02.2017 | Original Article

PPARα/γ antagonists reverse the ameliorative effects of osthole on hepatic lipid metabolism and inflammatory response in steatohepatitic rats

verfasst von: Xi Zhao, Feng Wang, Ruijun Zhou, Zengyan Zhu, Meilin Xie

Erschienen in: Inflammopharmacology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Our previous studies have indicated that osthole may ameliorate the hepatic lipid metabolism and inflammatory response in nonalcoholic steatohepatitic rats, but the underlying mechanisms remain unclear. This study aimed to determine whether the effects of osthole were mediated by the activation of hepatic peroxisome proliferator-activated receptor α/γ (PPARα/γ). A rat model with steatohepatitis was induced by orally feeding high-fat and high-sucrose emulsion for 6 weeks. These experimental rats were then treated with osthole (20 mg/kg), PPARα antagonist MK886 (1 mg/kg) plus osthole (20 mg/kg), PPARγ antagonist GW9662 (1 mg/kg) plus osthole (20 mg/kg) and MK886 (1 mg/kg) plus GW9662 (1 mg/kg) plus osthole (20 mg/kg) for 4 weeks. The results showed that after osthole treatment, the hepatic triglycerides, free fatty acids, tumor necrosis factor-α, monocyte chemotactic protein-1, interleukin-6 (IL-6), IL-8 and liver index decreased by 52.3, 31.0, 32.4, 28.9, 36.3, 29.3 and 29.9%, respectively, and the score of steatohepatitis also decreased by 70.0%, indicating that osthole improved the hepatic steatosis and inflammation. However, these effects of osthole were reduced or abrogated after simultaneous addition of the specific PPARα antagonist MK886 or/and the PPARγ antagonist GW9662, especially in the co-PPARα/γ antagonists-treated group. Importantly, the osthole-induced hepatic expressions of PPARα/γ proteins were decreased, and the osthole-regulated hepatic expressions of lipogenic and inflammatory gene proteins were also reversed by PPARα/γ antagonist treatment. These findings demonstrated that the ameliorative effect of osthole on nonalcoholic steatohepatitis was mediated by PPARα/γ activation, and osthole might be a natural dual PPARα/γ activator.
Literatur
Zurück zum Zitat Bhateja DK, Dhull DK, Gill A, Sidhu A, Sharma S, Reddy BVK, Padi SSV (2012) Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms. Eur J Pharmacol 674:33–43CrossRefPubMed Bhateja DK, Dhull DK, Gill A, Sidhu A, Sharma S, Reddy BVK, Padi SSV (2012) Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms. Eur J Pharmacol 674:33–43CrossRefPubMed
Zurück zum Zitat Bohinc BN, Diehl AM (2012) Mechanisms of disease progression in NASH: new paradigms. Clin Liver Dis 16:549–565CrossRefPubMed Bohinc BN, Diehl AM (2012) Mechanisms of disease progression in NASH: new paradigms. Clin Liver Dis 16:549–565CrossRefPubMed
Zurück zum Zitat Du R, Xue J, Wang HB, Zhang Y, Xie ML (2011) Osthol ameliorates fat milk-induced fatty liver in mice by regulation of hepatic sterol regulatory element-binding protein-1c/2-mediated target gene expression. Eur J Pharmacol 666:183–188CrossRefPubMed Du R, Xue J, Wang HB, Zhang Y, Xie ML (2011) Osthol ameliorates fat milk-induced fatty liver in mice by regulation of hepatic sterol regulatory element-binding protein-1c/2-mediated target gene expression. Eur J Pharmacol 666:183–188CrossRefPubMed
Zurück zum Zitat Farese RV, Cases S, Smith SJ (2000) Triglyceride synthesis: insights from the cloning of diacylglycerol acyltransferase. Curr Opin Lipidol 11:229–234CrossRefPubMed Farese RV, Cases S, Smith SJ (2000) Triglyceride synthesis: insights from the cloning of diacylglycerol acyltransferase. Curr Opin Lipidol 11:229–234CrossRefPubMed
Zurück zum Zitat Goyal S, Arora S, Bhatt TK, Das P, Sharma A, Kumari S, Arya DS (2010) Modulation of PPAR-gamma by telmisartan protects the heart against myocardial infarction in experimental diabetes. Chem Biol Interact 185:271–280CrossRefPubMed Goyal S, Arora S, Bhatt TK, Das P, Sharma A, Kumari S, Arya DS (2010) Modulation of PPAR-gamma by telmisartan protects the heart against myocardial infarction in experimental diabetes. Chem Biol Interact 185:271–280CrossRefPubMed
Zurück zum Zitat Kallwitz ER, McLachlan A, Cotler SJ (2008) Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease. World J Gastroenterol 14:22–28CrossRefPubMedPubMedCentral Kallwitz ER, McLachlan A, Cotler SJ (2008) Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease. World J Gastroenterol 14:22–28CrossRefPubMedPubMedCentral
Zurück zum Zitat Kim JC, Lee YH, Yu MK, Lee NH, Park JD, Bhattarai G, Yi HK (2012) Anti-inflammatory mechanism of PPARγ on LPS-induced pulp cells: role of the ROS removal activity. Arch Oral Biol 57:392–400CrossRefPubMed Kim JC, Lee YH, Yu MK, Lee NH, Park JD, Bhattarai G, Yi HK (2012) Anti-inflammatory mechanism of PPARγ on LPS-induced pulp cells: role of the ROS removal activity. Arch Oral Biol 57:392–400CrossRefPubMed
Zurück zum Zitat Kleiner DE, Brunt EM, van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal A (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321CrossRefPubMed Kleiner DE, Brunt EM, van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal A (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321CrossRefPubMed
Zurück zum Zitat Kohjima M, Enjoji M, Higuchi N, Kato M, Kotoh K, Yoshimo T, Fujino T, Yada M, Yada R, Harada N, Takayanagi R, Nakamuta M (2007) Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int J Mol Med 20:351–358PubMed Kohjima M, Enjoji M, Higuchi N, Kato M, Kotoh K, Yoshimo T, Fujino T, Yada M, Yada R, Harada N, Takayanagi R, Nakamuta M (2007) Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int J Mol Med 20:351–358PubMed
Zurück zum Zitat Konig B, Koch A, Spielmann J, Hilgenfeld C, Hirche F, Stangl GI, Eder K (2009) Activation of PPAR alpha and PPAR gamma reduces triacylglycerol synthesis in rat hepatoma cells by reduction of nuclear SREBP-1. Eur J Pharmacol 605:23–30CrossRefPubMed Konig B, Koch A, Spielmann J, Hilgenfeld C, Hirche F, Stangl GI, Eder K (2009) Activation of PPAR alpha and PPAR gamma reduces triacylglycerol synthesis in rat hepatoma cells by reduction of nuclear SREBP-1. Eur J Pharmacol 605:23–30CrossRefPubMed
Zurück zum Zitat Li L, Hai J, Li ZQ, Peng H, Li K, Weng XG (2014a) Resveratrol modulates autophagy and NF-kappaB activity in a murine model for treating non-alcoholic fatty liver disease. Food Chem Toxicol 63:166–173CrossRefPubMed Li L, Hai J, Li ZQ, Peng H, Li K, Weng XG (2014a) Resveratrol modulates autophagy and NF-kappaB activity in a murine model for treating non-alcoholic fatty liver disease. Food Chem Toxicol 63:166–173CrossRefPubMed
Zurück zum Zitat Li XW, Li Y, Yang WT, Xiao C, Fu SX, Deng QH, Ding HY, Wang Z, Liu GW, Li XB (2014b) SREBP-1c overexpression induces triglycerides accumulation through increasing lipid synthesis and decreasing lipid oxidation and VLDL assembly in bovine hepatocytes. J Steroid Biochem 143:174–182CrossRef Li XW, Li Y, Yang WT, Xiao C, Fu SX, Deng QH, Ding HY, Wang Z, Liu GW, Li XB (2014b) SREBP-1c overexpression induces triglycerides accumulation through increasing lipid synthesis and decreasing lipid oxidation and VLDL assembly in bovine hepatocytes. J Steroid Biochem 143:174–182CrossRef
Zurück zum Zitat Li ZP, Ji HJ, Song XY, Hu JF, Han N, Chen NH (2014c) Osthole attenuates the development of carrageenan-induced lung inflammation in rats. Int Immunopharmacol 20:33–36CrossRefPubMed Li ZP, Ji HJ, Song XY, Hu JF, Han N, Chen NH (2014c) Osthole attenuates the development of carrageenan-induced lung inflammation in rats. Int Immunopharmacol 20:33–36CrossRefPubMed
Zurück zum Zitat Lian QS (2003) Progress in study of chemical constituents and pharmacological effects of the fruit of Cnidium monnieri. Chin Med Mater 26:141–144 Lian QS (2003) Progress in study of chemical constituents and pharmacological effects of the fruit of Cnidium monnieri. Chin Med Mater 26:141–144
Zurück zum Zitat Mandard S, Muller M, Kersten S (2004) Peroxisome proliferator-activated receptor alpha target genes. Cell Mol Life Sci 61:393–416CrossRefPubMed Mandard S, Muller M, Kersten S (2004) Peroxisome proliferator-activated receptor alpha target genes. Cell Mol Life Sci 61:393–416CrossRefPubMed
Zurück zum Zitat Song F, Xie ML, Zhu LJ, Zhang KP, Xue J, Gu ZL (2006) Experimental study of osthole on treatment of hyperlipidemic and alcoholic fatty liver in animals. World J Gastroenterol 12:4359–4363CrossRefPubMedPubMedCentral Song F, Xie ML, Zhu LJ, Zhang KP, Xue J, Gu ZL (2006) Experimental study of osthole on treatment of hyperlipidemic and alcoholic fatty liver in animals. World J Gastroenterol 12:4359–4363CrossRefPubMedPubMedCentral
Zurück zum Zitat Stienstra R, Mandard S, Patsouris D, Maass C, Kersten S, Muller M (2007) Peroxisome peroliferator-activated receptor alpha protects against obesity-induced hepatic inflammation. Endocrinology 148:2753–2763CrossRefPubMed Stienstra R, Mandard S, Patsouris D, Maass C, Kersten S, Muller M (2007) Peroxisome peroliferator-activated receptor alpha protects against obesity-induced hepatic inflammation. Endocrinology 148:2753–2763CrossRefPubMed
Zurück zum Zitat Sun F, Xie ML, Xue J, Wang HB (2010) Osthol regulates hepatic PPARα-mediated lipogenic gene expression in alcoholic fatty liver murine. Phytomedicine 17:669–673CrossRefPubMed Sun F, Xie ML, Xue J, Wang HB (2010) Osthol regulates hepatic PPARα-mediated lipogenic gene expression in alcoholic fatty liver murine. Phytomedicine 17:669–673CrossRefPubMed
Zurück zum Zitat Takahashi N, Goto T, Taimatsu A, Egawa K, Katoh S, Kusudo T, Sakamoto T, Ohyane C, Lee JY, Kim YI, Uemura T, Hirai S, Kawada T (2009) Bixin regulates mRNA expression involved in adipogenesis and enhances insulin sensitivity in 3T3-L1 adipocytes through PPAR gamma activation. Biochem Biophys Res Commun 390:1372–1376CrossRefPubMed Takahashi N, Goto T, Taimatsu A, Egawa K, Katoh S, Kusudo T, Sakamoto T, Ohyane C, Lee JY, Kim YI, Uemura T, Hirai S, Kawada T (2009) Bixin regulates mRNA expression involved in adipogenesis and enhances insulin sensitivity in 3T3-L1 adipocytes through PPAR gamma activation. Biochem Biophys Res Commun 390:1372–1376CrossRefPubMed
Zurück zum Zitat Wahli W, Michalik L (2012) PPARs at the crossroads of lipid signaling and inflammation. Trends Endocrin Metab 23:351–363CrossRef Wahli W, Michalik L (2012) PPARs at the crossroads of lipid signaling and inflammation. Trends Endocrin Metab 23:351–363CrossRef
Zurück zum Zitat Yan DG, Lehto M, Rasilainen L, Metso J, Ehnholm C, Yla-Herttuala S, Jauhiainen M, Olkkonen VM (2007) Oxysterol binding protein induces upregulation of SREBP-1c and enhances hepatic lipogenesis. Arterioscler Thromb Vasc Biol 27:1108–1114CrossRefPubMed Yan DG, Lehto M, Rasilainen L, Metso J, Ehnholm C, Yla-Herttuala S, Jauhiainen M, Olkkonen VM (2007) Oxysterol binding protein induces upregulation of SREBP-1c and enhances hepatic lipogenesis. Arterioscler Thromb Vasc Biol 27:1108–1114CrossRefPubMed
Zurück zum Zitat Ye YY, Han XH, Guo BF, Sun ZP, Liu S (2013) Combination treatment with platycodin D and osthole inhibits cell proliferation and invasion in mammary carcinoma cell lines. Environ Toxicol Pharmacol 36:115–124CrossRefPubMed Ye YY, Han XH, Guo BF, Sun ZP, Liu S (2013) Combination treatment with platycodin D and osthole inhibits cell proliferation and invasion in mammary carcinoma cell lines. Environ Toxicol Pharmacol 36:115–124CrossRefPubMed
Zurück zum Zitat Zhang Y, Xie ML, Xue J, Gu ZL (2007a) Osthole improves fat milk-induced fatty liver in rats: modulation of hepatic PPAR-alpha/gamma-mediated lipogenic gene expression. Planta Med 73:718–724CrossRefPubMed Zhang Y, Xie ML, Xue J, Gu ZL (2007a) Osthole improves fat milk-induced fatty liver in rats: modulation of hepatic PPAR-alpha/gamma-mediated lipogenic gene expression. Planta Med 73:718–724CrossRefPubMed
Zurück zum Zitat Zhang Y, Xie ML, Zhu LJ, Gu ZL (2007b) Therapeutic effect of osthole on hyperlipidemic fatty liver in rats. Acta Pharmacol Sin 28:398–403CrossRefPubMed Zhang Y, Xie ML, Zhu LJ, Gu ZL (2007b) Therapeutic effect of osthole on hyperlipidemic fatty liver in rats. Acta Pharmacol Sin 28:398–403CrossRefPubMed
Zurück zum Zitat Zhang JJ, Xue J, Wang HB, Zhang Y, Xie ML (2011) Osthole improves alcohol-induced fatty liver in mice by reduction of hepatic oxidative stress. Phytother Res 25:638–643CrossRefPubMed Zhang JJ, Xue J, Wang HB, Zhang Y, Xie ML (2011) Osthole improves alcohol-induced fatty liver in mice by reduction of hepatic oxidative stress. Phytother Res 25:638–643CrossRefPubMed
Zurück zum Zitat Zhang Y, Cui Y, Wang XL, Shang X, Qi ZG, Xue J, Zhao X, Deng M, Xie ML (2015) PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats. Cytokine 75:127–135CrossRefPubMed Zhang Y, Cui Y, Wang XL, Shang X, Qi ZG, Xue J, Zhao X, Deng M, Xie ML (2015) PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats. Cytokine 75:127–135CrossRefPubMed
Zurück zum Zitat Zhao JS, Zhu FS, Liu S, Yang CQ, Chen XM (2012) Pioglitazone ameliorates nonalcoholic steatohepatitis by down-regulating hepatic nuclear factor-kappa B and cyclooxygenases-2 expression in rats. Chin Med J 125:2316–2321PubMed Zhao JS, Zhu FS, Liu S, Yang CQ, Chen XM (2012) Pioglitazone ameliorates nonalcoholic steatohepatitis by down-regulating hepatic nuclear factor-kappa B and cyclooxygenases-2 expression in rats. Chin Med J 125:2316–2321PubMed
Zurück zum Zitat Zhao X, Xue J, Wang XL, Zhang Y, Deng M, Xie ML (2014) Involvement of hepatic peroxisome proliferator-activated receptor α/γ in the therapeutic effect of osthole on high-fat and high-sucrose-induced steatohepatitis in rats. Int Immunopharmacol 22:176–181CrossRefPubMed Zhao X, Xue J, Wang XL, Zhang Y, Deng M, Xie ML (2014) Involvement of hepatic peroxisome proliferator-activated receptor α/γ in the therapeutic effect of osthole on high-fat and high-sucrose-induced steatohepatitis in rats. Int Immunopharmacol 22:176–181CrossRefPubMed
Zurück zum Zitat Zou YH, Li J, Lu C, Wang JQ, Ge JF, Huang Y, Zhang L, Wang YY (2006) High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Life Sci 79:1100–1107CrossRefPubMed Zou YH, Li J, Lu C, Wang JQ, Ge JF, Huang Y, Zhang L, Wang YY (2006) High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Life Sci 79:1100–1107CrossRefPubMed
Metadaten
Titel
PPARα/γ antagonists reverse the ameliorative effects of osthole on hepatic lipid metabolism and inflammatory response in steatohepatitic rats
verfasst von
Xi Zhao
Feng Wang
Ruijun Zhou
Zengyan Zhu
Meilin Xie
Publikationsdatum
25.02.2017
Verlag
Springer International Publishing
Erschienen in
Inflammopharmacology / Ausgabe 2/2018
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608
DOI
https://doi.org/10.1007/s10787-017-0327-2

Weitere Artikel der Ausgabe 2/2018

Inflammopharmacology 2/2018 Zur Ausgabe